Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk factors for mortality in pregnant women with SARS-CoV-2 infection

View ORCID ProfileRaigam J. Martinez-Portilla, Alexandros Sotiriadis, Johnatan Torres-Torres, Chatzakis Christos, Ameth Hawkins-Villarreal, Jose R. Villafan-Bernal, Rodolfo A. Gurrola-Ochoa, Francesc Figueras
doi: https://doi.org/10.1101/2020.05.31.20107276
Raigam J. Martinez-Portilla
1Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Institut d’lnvestigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Centre for Biomedical Research on Rare Diseases (CIBER-ER), Spain
2Centre for Evidence-Based Medicine, Nuffield Department of Primary Health Sciences, University of Oxford, Oxford, UK
3Second Department of Obstetrics and Gynecology, Faculty of Medicine, Aristotle University of Thessaloniki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raigam J. Martinez-Portilla
Alexandros Sotiriadis
3Second Department of Obstetrics and Gynecology, Faculty of Medicine, Aristotle University of Thessaloniki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johnatan Torres-Torres
1Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Institut d’lnvestigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Centre for Biomedical Research on Rare Diseases (CIBER-ER), Spain
4General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chatzakis Christos
3Second Department of Obstetrics and Gynecology, Faculty of Medicine, Aristotle University of Thessaloniki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ameth Hawkins-Villarreal
1Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Institut d’lnvestigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Centre for Biomedical Research on Rare Diseases (CIBER-ER), Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose R. Villafan-Bernal
5CátedrasCONACYT, Instituto Nacional de Medicina Genómica, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodolfo A. Gurrola-Ochoa
4General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesc Figueras
1Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Institut d’lnvestigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Centre for Biomedical Research on Rare Diseases (CIBER-ER), Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ffiguera@clinic.ub.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Since the first case of pneumonia was described, SARS-CoV-2 infection (coronavirus disease [COVID]-19) rapidly spread worldwide With 94,288 infections and more than 10,000 deaths, Mexico is the third Latin-American country in number of confirmed cases and second in mortality1. A major risk factor for adverse outcome in COVID-19 infection is the presence of advance age, co-morbidities including diabetes, hypertension and obesity among other non-communicable diseases2. Epidemiological data from high-prevalence countries reveal that compared to men, women are less likely to die or to require hospital admission to intensive care. This may suggest that pregnant women are not more susceptible to infection or to experience serious complications. However, whether the presence of co-morbidities or advanced maternal age confers a higher risk of adverse outcome in pregnant women with COVID-19 is unknown3.

In this research letter, we aimed at evaluating the risk factor associated with maternal mortality secondary to COVID-19 infection in a middle-income country.

Advanced maternal age is linked to an increased risk of mortality, while diabetes is the most important risk factor for maternal death. This is partly explained by an increasing incidence of non-communicable diseases in women of advanced age which is a common feature in most countries4. In the last decades, low- and middle-income countries have experienced accelerated socio-cultural changes associated with its incorporation into the international economic community, which have increased the number of obese and diabetic population, including pregnant women5. This has caused an increased risk for complications and fatality among COVID-19 positive population2,3. Thus, policies for reducing obesity and diabetes in low- and middle-income countries are most needed to reduce the mortality of COVID-19 in pregnant women.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is an observational study using freely available data. There is no need for trial registration

Funding Statement

There were no fundings for this study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the General Hospital's Ethics committee No. DI/20/112/04/24

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available by correspondence by contacting the corresponding author

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 02, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors for mortality in pregnant women with SARS-CoV-2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk factors for mortality in pregnant women with SARS-CoV-2 infection
Raigam J. Martinez-Portilla, Alexandros Sotiriadis, Johnatan Torres-Torres, Chatzakis Christos, Ameth Hawkins-Villarreal, Jose R. Villafan-Bernal, Rodolfo A. Gurrola-Ochoa, Francesc Figueras
medRxiv 2020.05.31.20107276; doi: https://doi.org/10.1101/2020.05.31.20107276
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Risk factors for mortality in pregnant women with SARS-CoV-2 infection
Raigam J. Martinez-Portilla, Alexandros Sotiriadis, Johnatan Torres-Torres, Chatzakis Christos, Ameth Hawkins-Villarreal, Jose R. Villafan-Bernal, Rodolfo A. Gurrola-Ochoa, Francesc Figueras
medRxiv 2020.05.31.20107276; doi: https://doi.org/10.1101/2020.05.31.20107276

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8987)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1959)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10809)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1903)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)